Increasing scrutiny and an evolving understanding of the impact of capsid impurities in recombinant adeno-associated virus (rAAV)-based therapies has catalyzed efforts to eliminate them from ...
But last year we got the best sense yet of how LLMs function, as researchers at top AI companies began developing new ways to ...
Simulations Plus (SLP) announced that it has been awarded a newly funded grant from the U.S. Food and Drug Administration FDA to use physiologically based pharmacokinetic PBPK approaches in GastroPlus ...
Models of biopharmaceutical production processes are more accurate and predictive if all downstream steps are considered together rather than individually. At least that’s according to researchers at ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
Applied BioMath, the industry-leader in applying mechanistic modeling, simulation, and analysis to de-risk and accelerate drug research and development, announced a collaboration with Revitope for an ...
Progress in mechanistic interpretability could lead to major advances in making large AI models safe and bias-free. The Anthropic researchers, in other words, wanted to learn about the higher-order ...